Published in PLoS Med on December 21, 2010
Public health and the epidemic of incarceration. Annu Rev Public Health (2012) 1.85
Tuberculosis in a South African prison - a transmission modelling analysis. S Afr Med J (2011) 1.24
High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One (2014) 1.18
The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert. PLoS One (2013) 1.17
State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control. PLoS One (2013) 1.16
Prevalence of smear positive pulmonary tuberculosis among prisoners in North Gondar Zone Prison, northwest Ethiopia. BMC Infect Dis (2012) 1.15
Tuberculosis incidence and treatment completion among Ugandan prison inmates. Int J Tuberc Lung Dis (2014) 1.14
Assessing trends and predictors of tuberculosis in Taiwan. BMC Public Health (2012) 1.13
Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis (2015) 1.13
Criminal justice reform as HIV and TB prevention in African prisons. PLoS Med (2012) 1.08
The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS One (2013) 1.06
Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study. BMC Infect Dis (2015) 1.03
Tuberculosis: epidemiology and control. Mediterr J Hematol Infect Dis (2014) 1.02
Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia. Int J Tuberc Lung Dis (2013) 1.01
A pragmatic approach to measuring, monitoring and evaluating interventions for improved tuberculosis case detection. Int Health (2014) 0.98
The health crisis of tuberculosis in prisons extends beyond the prison walls. PLoS Med (2010) 0.96
Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open (2012) 0.93
Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis. Clin Dev Immunol (2012) 0.91
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet (2016) 0.90
The Impact of Ventilation and Early Diagnosis on Tuberculosis Transmission in Brazilian Prisons. Am J Trop Med Hyg (2015) 0.90
Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia. BMC Infect Dis (2013) 0.90
Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis (2014) 0.90
High seroprevalence of Toxoplasma gondii infection in inmates: A case control study in Durango City, Mexico. Eur J Microbiol Immunol (Bp) (2014) 0.88
Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg Infect Dis (2015) 0.88
Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. BMC Public Health (2014) 0.87
Half of Pulmonary Tuberculosis Cases Were Left Undiagnosed in Prisons of the Tigray Region of Ethiopia: Implications for Tuberculosis Control. PLoS One (2016) 0.85
High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991-2010, Italy. Emerg Infect Dis (2013) 0.84
Screening for tuberculosis and testing for human immunodeficiency virus in Zambian prisons. Bull World Health Organ (2015) 0.84
Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany. PLoS One (2014) 0.83
High incidence of tuberculosis, low sensitivity of current diagnostic scheme and prolonged culture positivity in four colombian prisons. A cohort study. PLoS One (2013) 0.82
Modeling the spread of tuberculosis in semiclosed communities. Comput Math Methods Med (2013) 0.80
A comparative study on the prevalence and risk factors of tuberculosis among the prisoners in khuzestan, South-west iran. Jundishapur J Microbiol (2014) 0.79
Prevalence of previously undetected tuberculosis and underlying risk factors for transmission in a prison setting in Ibadan, south-western Nigeria. Afr J Med Med Sci (2014) 0.78
The outcome of tuberculosis treatment in subjects with chronic kidney disease in Brazil: a multinomial analysis. J Bras Pneumol (2013) 0.78
Creating a Powerful Platform to Explore Health in a Correctional Population: A Record Linkage Study. PLoS One (2016) 0.77
Combined antiretroviral and anti-tuberculosis drug resistance following incarceration. South Afr J HIV Med (2013) 0.77
Implementing a large-scale systematic tuberculosis screening program in correctional facilities in South Africa. Open Forum Infect Dis (2015) 0.77
Vaccinations in prisons: A shot in the arm for community health. Hum Vaccin Immunother (2015) 0.77
Prevalence of Pulmonary Tuberculosis among Prison Inmates in Ethiopia, a Cross-Sectional Study. PLoS One (2015) 0.77
Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays. Public Health Action (2015) 0.77
The Rikers Island Hot Spotters: Defining the Needs of the Most Frequently Incarcerated. Am J Public Health (2015) 0.76
Effect of active case finding on prevalence and transmission of pulmonary tuberculosis in Dhaka Central Jail, Bangladesh. PLoS One (2015) 0.76
The diagnostic accuracy of urine lipoarabinomannan test for tuberculosis screening in a South African correctional facility. PLoS One (2015) 0.75
Developing a human rights-based program for tuberculosis control in Georgian prisons. Health Hum Rights (2011) 0.75
Risk Factors for Primary Pulmonary TB in Almaty Region, Kazakhstan: A Matched Case-Control Study. Iran J Public Health (2016) 0.75
Substantial overlap between incarceration and tuberculosis in atlanta, georgia, 2011. Open Forum Infect Dis (2014) 0.75
Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc (2016) 0.75
Household crowding as a potential mediator of socioeconomic determinants of tuberculosis incidence in Brazil. PLoS One (2017) 0.75
Drug resistance and population structure of M.tuberculosis isolates from prisons and communities in Ethiopia. BMC Infect Dis (2016) 0.75
Prevalence of Pulmonary Tuberculosis among Prison Inmates at Mbarara Central Prison, South Western Uganda. Adv Res (2014) 0.75
Impact of mass-screening on tuberculosis incidence in a prospective cohort of Brazilian prisoners. BMC Infect Dis (2016) 0.75
Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts. PLoS One (2017) 0.75
Point prevalence and incidence of Mycobacterium tuberculosis complex in captive elephants in the United States of America. Vet Q (2013) 0.75
Prisons and public health. Open Med (2011) 0.75
Prevalence of latent Mycobacterium tuberculosis infection in prisoners. J Bras Pneumol (2016) 0.75
Can social history variables predict prison inmates' risk for latent tuberculosis infection? Tuberc Res Treat (2012) 0.75
Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan. PLoS One (2017) 0.75
Enhanced tuberculosis case finding through advocacy and sensitisation meetings in prisons of Central India. Public Health Action (2017) 0.75
A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa. PLoS One (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum (1953) 10.06
Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep (2005) 8.91
Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med (2006) 4.96
Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis (2007) 4.04
Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA (1989) 3.67
Transmission of tuberculosis in a jail. Ann Intern Med (1999) 2.58
Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol (1994) 2.20
Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLoS One (2009) 1.87
Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A (2008) 1.86
A longitudinal study of transmission of tuberculosis in a large prison population. Am J Respir Crit Care Med (1997) 1.65
Pitfalls of tuberculosis programmes in prisons. BMJ (1997) 1.58
Tuberculosis behind bars in Israel: policy making within a dynamic situation. Isr Med Assoc J (2008) 1.54
Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis (2006) 1.54
Tuberculosis in prisons in countries with high prevalence. BMJ (2000) 1.41
Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis (1997) 1.29
Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J (2009) 1.26
Smear positive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouaké, Ivory Coast. Int J Tuberc Lung Dis (1997) 1.23
Prevention of infectious disease transmission in correctional settings: a review. Public Health (2005) 1.19
Tuberculosis and HIV infection among female inmates in São Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.05
Tuberculosis behind bars in developing countries: a hidden shame to public health. Trans R Soc Trop Med Hyg (2008) 0.96
Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS (2000) 0.95
A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis (2000) 0.94
[Tuberculosis among city jail inmates in Campinas, São Paulo, Brazil]. Rev Panam Salud Publica (2004) 0.94
Persistence of a strain of Mycobacterium tuberculosis in a prison system. Int J Tuberc Lung Dis (2004) 0.92
Decentralization of the DOTS programme within a Russian penitentiary system. How to ensure the continuity of tuberculosis treatment in pre-trial detention centres. Eur J Public Health (2002) 0.91
Transmission of Mycobacterium tuberculosis in a California State Prison, 1991. Am J Public Health (1997) 0.89
Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987-2000. Int J Tuberc Lung Dis (2002) 0.88
Incidence of tuberculosis infection among New York State prison employees. Am J Public Health (1997) 0.87
Tuberculosis control in the New York State Department of Correctional Services: a case management approach. Am J Infect Control (1998) 0.86
Incidence of tuberculosis and the importance of treatment of latent tuberculosis infection in a Spanish prison population. Int J Tuberc Lung Dis (2001) 0.86
TB surveillance in correctional institutions in Hong Kong, 1999-2005. Int J Tuberc Lung Dis (2008) 0.86
Pulmonary tuberculosis in two remand prisons (SIZOs) in St Petersburg, Russia. Euro Surveill (2005) 0.84
The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis (2001) 0.84
[Comparative analysis of tuberculosis morbidity trends in the penitentiary and civil health care systems of the Udmurt Republic over 10 years]. Probl Tuberk Bolezn Legk (2007) 0.84
Risk of tuberculosis in correctional healthcare workers. J Occup Environ Med (2005) 0.83
[Organization of tuberculosis-controlling work and its efficiency in the penitentiaries of the Ivanovo Region]. Probl Tuberk Bolezn Legk (2003) 0.81
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet (2010) 10.21
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet (2007) 9.71
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet (2009) 7.22
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis (2008) 5.94
Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 5.93
Global incidence of multidrug-resistant tuberculosis. J Infect Dis (2006) 5.42
The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis (2003) 5.09
The population dynamics and control of tuberculosis. Science (2010) 5.08
Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (2003) 4.87
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet (2006) 4.73
HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis (2010) 4.19
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis (2007) 3.96
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA (2008) 3.78
Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One (2011) 3.57
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44
Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis (2006) 3.32
Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health (2008) 3.32
Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med (2004) 3.26
AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS (2009) 2.92
Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet (2012) 2.83
Impact of malaria control on childhood anaemia in Africa -- a quantitative review. Trop Med Int Health (2004) 2.80
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science (2002) 2.65
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis (2003) 2.49
Tuberculosis among health care workers. Emerg Infect Dis (2011) 2.49
MDR tuberculosis--critical steps for prevention and control. N Engl J Med (2010) 2.49
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis (2006) 2.48
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis (2002) 2.33
A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol (2009) 2.20
Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS (2003) 2.11
Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health (2005) 2.09
Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data. Lancet (2013) 2.03
Eliminating human tuberculosis in the twenty-first century. J R Soc Interface (2008) 2.00
Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS (2010) 1.77
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
What is the limit to case detection under the DOTS strategy for tuberculosis control? Tuberculosis (Edinb) (2003) 1.72
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One (2008) 1.61
Pattern and determinants of hospitalization during heat waves: an ecologic study. BMC Public Health (2007) 1.59
Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bull World Health Organ (2009) 1.59
Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One (2011) 1.51
Preventing HIV transmission with antiretrovirals. Bull World Health Organ (2009) 1.50
Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis (2007) 1.49
How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ (2003) 1.43
High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr (2002) 1.43
Lung cancer risk: effect of dairy farming and the consequence of removing that occupational exposure. Am J Epidemiol (2005) 1.40
Drug-Resistant tuberculosis, KwaZulu-Natal, South Africa, 2001-2007. Emerg Infect Dis (2011) 1.36
The unexplored story of HIV and ageing. Bull World Health Organ (2009) 1.34
Increased cancer risk among surgeons in an orthopaedic hospital. Occup Med (Lond) (2005) 1.33
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
Measuring accuracy of discharge diagnoses for a region-wide surveillance of hospitalized strokes. Stroke (2005) 1.29
Contrasting patterns of hospital admissions and mortality during heat waves: are deaths from circulatory disease a real excess or an artifact? Med Hypotheses (2006) 1.19
Comment to "Vinyl chloride exposure and cirrhosis: a systematic review and meta-analysis". Dig Liver Dis (2013) 1.14
Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis (2006) 1.13
Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer (2012) 1.12
The benefits of early treatment for HIV. AIDS (2010) 1.11
Epidemiologic evidence of cancer risk in textile industry workers: a review and update. Toxicol Ind Health (2002) 1.03
Strategies to prevent and treat cardiovascular risk in cancer patients. Semin Oncol (2013) 1.00
Viewpoint TB diagnostics: what does the world really need? J Infect Dis (2011) 0.99
Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake. Environ Health Perspect (2004) 0.99
Role of acute infection in HIV transmission. Lancet (2011) 0.98
Slow elimination of multidrug-resistant tuberculosis. Sci Transl Med (2009) 0.96
Cost-effectiveness of antiretroviral therapy for prevention. Curr HIV Res (2011) 0.95
Endotoxin exposure and lung cancer mortality by type of farming: is there a hidden dose-response relationship? Ann Agric Environ Med (2003) 0.92
Seasonal variations in injury rates in children: evidence from a 10-year study in the Veneto Region, Italy. Int J Inj Contr Saf Promot (2012) 0.92
Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB. Travel Med Infect Dis (2007) 0.92
Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenya. AIDS Res Treat (2012) 0.92
Global Tuberculosis Control: Toward the 2015 Targets and Beyond. Ann Intern Med (2015) 0.92
Limitations on human rights: are they justifiable to reduce the burden of TB in the era of MDR- and XDR-TB? Health Hum Rights (2008) 0.91
Cardiac toxicity of anticancer agents. Curr Cardiol Rep (2013) 0.90
Seat belt use among rear passengers: validity of self-reported versus observational measures. BMC Public Health (2008) 0.89
Mitochondrial DNA copy number and exposure to polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev (2013) 0.89
Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: dose-response relationships. Am J Ind Med (2009) 0.88
Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe. Epidemics (2011) 0.88
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. Am J Respir Crit Care Med (2002) 0.88
Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases. Cardiovasc Diabetol (2007) 0.87
Impact of HIV on novel therapies for tuberculosis control. AIDS (2008) 0.87
A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health (2010) 0.87
Evidence-based policy on road safety: the effect of the demerit points system on seat belt use and health outcomes. J Epidemiol Community Health (2007) 0.87
Accuracy and reproducibility of pleural effusion cytology. Leg Med (Tokyo) (2007) 0.86
Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic. Curr HIV/AIDS Rep (2014) 0.85
Effect of the new diagnostic criteria for ST-elevation and non-ST-elevation acute myocardial infarction on 4-year hospitalization: an analysis of hospital discharge records in the Veneto Region. J Cardiovasc Med (Hagerstown) (2006) 0.84
Maternal exposures and risk of spontaneous abortion before and after a community oriented health education campaign. Eur J Public Health (2010) 0.84
Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies. BMJ Open (2014) 0.83